Caredx Inc [CDNA] stock is trading at $20.19, down -1.85%. An important factor to consider is whether the stock is rising or falling in short-term value. The CDNA shares have gain 7.34% over the last week, with a monthly amount glided 1.97%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Caredx Inc [NASDAQ: CDNA] stock has seen the most recent analyst activity on January 06, 2026, when Craig Hallum downgraded its rating to a Hold but kept the price target unchanged to $26 for it. On January 15, 2025, upgrade upgraded it’s rating to Equal Weight and revised its price target to $24 on the stock. Wells Fargo started tracking the stock assigning an Underweight rating and suggested a price target of $28 on August 28, 2024. BTIG Research upgraded its rating to a Buy but $40 remained the price target by the analyst firm on August 19, 2024. Raymond James downgraded its rating to Mkt Perform for this stock on May 13, 2024. In a note dated May 01, 2024, Craig Hallum upgraded a Buy rating on this stock but restated the target price of $15.
Caredx Inc [CDNA] stock has fluctuated between $10.96 and $25.95 over the past year. Currently, Wall Street analysts expect the stock to reach $22 within the next 12 months. Caredx Inc [NASDAQ: CDNA] shares were valued at $20.19 at the most recent close of the market. An investor can expect a potential return of 8.96% based on the average CDNA price forecast.
Analyzing the CDNA fundamentals
Caredx Inc [NASDAQ:CDNA] reported sales of 358.00M for the trailing twelve months, which represents a growth of 20.72%. Gross Profit Margin for this corporation currently stands at 0.67% with Operating Profit Margin at 0.15%, Pretax Profit Margin comes in at 0.17%, and Net Profit Margin reading is 0.17%. To continue investigating profitability, this company’s Return on Assets is posted at 0.14, Equity is 0.17 and Total Capital is 0.16. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.09.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance.
Ratios To Look Out For
For context, Caredx Inc’s Current Ratio is 3.03. On the other hand, the Quick Ratio is 2.75, and the Cash Ratio is 0.92. Considering the valuation of this stock, the price to sales ratio is 2.90, the price to book ratio is 3.34 and price to earnings (TTM) ratio is 16.93.
Transactions by insiders
Recent insider trading involved Novack Jeffrey Adam, Secretary and General Counsel, that happened on Dec 04 ’25 when 7293.0 shares were sold. Officer, JEFFREY NOVACK completed a deal on Dec 04 ’25 to buy 7293.0 shares. Meanwhile, Secretary and General Counsel Novack Jeffrey Adam sold 2688.0 shares on Nov 07 ’25.
